Dillon & Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.3M | Buy |
4,228
+1,706
| +68% | +$1.33M | 0.45% | 38 |
|
|
2025
Q1 | $2.08M | Buy |
2,522
+1,276
| +102% | +$1.05M | 0.31% | 44 |
|
|
2024
Q4 | $962K | Buy |
1,246
+794
| +176% | +$613K | 0.13% | 56 |
|
|
2024
Q3 | $400K | Hold |
452
| – | – | 0.06% | 66 |
|
|
2024
Q2 | $409K | Hold |
452
| – | – | 0.06% | 67 |
|
|
2024
Q1 | $352K | Hold |
452
| – | – | 0.06% | 69 |
|
|
2023
Q4 | $264K | Sell |
452
-19
| -4% | -$11.1K | 0.05% | 73 |
|
|
2023
Q3 | $253K | Buy |
471
+20
| +4% | +$10.7K | 0.05% | 72 |
|
|
2023
Q2 | $212K | Buy |
+451
| New | +$212K | 0.04% | 77 |
|